Insights

We’re acknowledged for our strong market insight and technical know-how

Insights

Penningtons Manches Cooper advises Hutano Diagnostics Limited on its sale to EDX Medical Group PLC

23 October 2023
Read more
News

Penningtons Manches Cooper advises Cibus Fund II on its acquisition of leading UK cell-grown tree producer Alba Trees

27 February 2023
Read more
Insights

Penningtons Manches Cooper advises leading provider of testing, consulting, information, and compliance services, Smithers, on its acquisition of ResChem Analytical Limited

19 January 2023
Read more
News

Penningtons Manches Cooper advises Source Health Economics on its sale to Waterland-backed SCIRIS

19 January 2023
Read more
Insights

Penningtons Manches Cooper advises Simply Sustainable on its majority investment from Agathos Management LLP

4 January 2023
Read more
Insights

Advising SiXworks on their investment from Chiltern Capital

4 November 2022
Read more
News

Penningtons Manches Cooper advises Titian Software on majority investment from Battery Ventures

12 July 2022
Read more
News

Penningtons Manches Cooper advises US company Echo Healthcare on its cross-border acquisition of Immersive Interactive

17 June 2022
Read more
News

Penningtons Manches Cooper advises bioanalysis and toxicology laboratory Analytical Services International on acquisition by Forensic Access

23 March 2022
Read more
Insights

Penningtons Manches Cooper advises next generation virus diagnostic company OxDX on its spin-out from Oxford University

18 February 2022
Read more
Insights

Corporate team advises on major cross-border life sciences transaction

27 October 2021
Read more
Insights

Penningtons Manches Cooper advises on cross-border sale of ITSM software developer

25 August 2021
Read more